Clinical Trials Directory

Trials / Conditions / Erythropoietin

Erythropoietin

11 registered clinical trials studyying Erythropoietin1 currently recruiting.

StatusTrialSponsorPhase
RecruitingErythropoietin for Neonatal Encephalopathy in LMIC (EMBRACE Trial)
NCT05395195
Imperial College LondonPhase 3
UnknownErythropoietin Gel as an Adjunct to Split-Thickness Apically Positioned Flap in Augmentation of Attached Gingi
NCT05683782
Ain Shams UniversityPhase 4
UnknownEffect of Intravenous Methylprednisolone and Intravenous Erythropoietin in Toxic Optic Neuropathies: Randomize
NCT05748561
Asociación para Evitar la Ceguera en MéxicoPhase 2 / Phase 3
CompletedLow Sirtuin-1 Levels Are Linked to Erythropoietin Resistance in Hemodialysis Patients.
NCT06877286
Cuma Bulent Gul
CompletedOral Vitamin C Administration on Erythropoietin Dosing Requirement in End-Stage Renal Disease Patients on Regu
NCT07076108
Ain Shams UniversityN/A
UnknownCombination Therapy of Umbilical Cord Blood and Erythropoietin for Stroke Paients
NCT04013646
Bundang CHA HospitalPhase 1 / Phase 2
CompletedEvaluating Erythropoietin as an Indicator for Possible Kidney Injury After Cardiac Surgery
NCT01393418
University of Michigan
UnknownIntraocular Pharmacokinetics of Erythropoietin After Single Intravitreal Injection in Human
NCT01131533
Hallym University Medical CenterN/A
UnknownA Prospective, Immunogenicity Surveillance Registry of Erythropoiesis Stimulating Agent (ESA) With Subcutaneou
NCT00799019
Chulalongkorn University
CompletedErythropoietin Resistance in Anemia of Chronic Kidney Disease
NCT00526747
Duke University
TerminatedHigh-Dose Erythropoietin in Extremely Premature Infants to Prevent/Attenuate Brain Injury: A Phase II Study
NCT00589953
Atlantic Health SystemPhase 2